<?xml version="1.0" encoding="UTF-8"?>
<p id="Par44">Moreover, bronchial epithelial cells of atopic asthmatics have shown to have increased RV replication, deficient IFN-Î³ release, and enhanced cell lysis [
 <xref ref-type="bibr" rid="CR83">83</xref>]. Studies with omalizumab, anti-IgE, have shown that neutralizing IgE-mediated inflammation can enhance IFN responses and reduce virus-induced asthma exacerbations in children [
 <xref ref-type="bibr" rid="CR84">84</xref>]. This finding suggests that neutralizing IgE indirectly improve anti-viral responses.
</p>
